Genedx Is A Genomics Company Based In Stamfordconnecticutspecializing In Rare Disease Diagnostic Testingparticularly For Pediatric And Neonatal Intensive Care Unitnicucasesfounded In 2000The Company Has Over Two Decades Of Experience In Genetic Sequencing And Is Recognized For Its Leadership In Next Generation Sequencingngsdiagnosticsgenedx Became Publicly Traded On Nasdaq Under The Ticker Wgs In January 2023 The Company Offers A Range Of Diagnostic Testing Servicesincluding Whole Exome And Genome Sequencingand Advanced Clinical Interpretation Using A Proprietary Platformgenedx Utilizes One Of The Largest Rare Disease Datasetswith Over 750 000 Exomes And Genomes Sequencedto Enhance Diagnostic Accuracy And Support Drug Discoveryit Collaborates With Healthcare Providers To Deliver Targeted Care Plans And Emphasizes The Importance Of Early Diagnosis And Personalized Treatment For Patientsparticularly Children With Undiagnosed Genetic Conditionsgenedx Is Committed To Improving Health Outcomes Through Genetic Insights And Innovative Healthcare Solutions
